01 1SMS Pharmaceuticals
01 1ARIPIPRAZOLE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2021-02-18
Pay. Date : 2021-02-08
DMF Number : 29991
Submission : 2015-11-04
Status : Active
Type : II
20
Sms Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ARIPIPRAZOLE USP, with a corresponding US DMF Number 29991.
Remarkably, this DMF maintains an Active status since its submission on November 04, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 18, 2021, and payment made on February 08, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II
